Cristina Vazquez Guillamet

Medicine & Life Sciences

1. Septic Shock 100%
2. Sepsis 87%
3. Infections 82%
4. Anti-Bacterial Agents 69%
5. Critical Illness 66%
6. Intensive Care Units 61%
7. Ventilator-Associated Pneumonia 56%
8. Lung 55%
9. Mortality 52%
10. Methicillin-Resistant Staphylococcus aureus 47%
11. Artificial Respiration 46%
12. Transplant Recipients 45%
13. Gram-Negative Bacteria 43%
14. Antimicrobial Stewardship 42%
15. Coronavirus 40%
16. Bronchoalveolar Lavage 32%
17. Critical Care 31%
18. Pneumonia 31%
19. Cohort Studies 29%
20. Acinetobacter 28%
21. Respiratory Tract Infections 27%
22. Microbial Drug Resistance 27%
23. Lung Transplantation 24%
24. Decision Making 24%
25. Therapeutics 24%
26. Thorax 23%
27. Healthcare-Associated Pneumonia 23%
28. Hospital Rapid Response Team 23%
29. B7-H1 Antigen 23%
30. Bacteremia 22%
31. Cefepime 21%
32. Clinical Decision Rules 21%
33. Hospital Mortality 20%
34. Skilled Nursing Facilities 20%
35. Candidemia 20%
36. Epidemiology 20%
37. Soft Tissue Infections 20%
38. Odds Ratio 19%
39. Meropenem 19%
40. Tazobactam Drug Combination Piperacillin 19%
41. Interleukin-6 Receptors 19%
42. Terminal Care 19%
43. Retrospective Studies 19%
44. Gram-Positive Bacteria 18%
45. Pseudomonas 18%
46. Numbers Needed To Treat 18%
47. Confidence Intervals 17%
48. Immunocompromised Host 17%
49. Human Influenza 17%
50. Multiple Drug Resistance 17%